Login

Switch On Your HIV Smarts.

What you need to know about HIV two-drug regimens

What you need to know about HIV two-drug regimens

, by Emily Land

There is one currently recommended two-drug regimen option for people living with HIV. Here’s a summary of challenges with the current option, and an overview of two other combinations currently being tested. Read More

HIV care for people of any immigration status in San Francisco Bay Area

HIV care for people of any immigration status in San Francisco Bay Area

, by Emily Land

Don’t let fear of deportation stop you from accessing HIV services. Here are resources in the San Francisco Bay Area. Read More

Almost, but not quite, HIV undetectable. Is that a problem?

Almost, but not quite, HIV undetectable. Is that a problem?

, by Emily Land

A new study bolsters our understanding of when low-level viremia can affect health—and when it is likely not an issue. Read More

“Undetectable”: Your Burning Questions Answered

“Undetectable”: Your Burning Questions Answered

, by Emily Land

Get an HIV doctor’s answers to your burning questions about undetectable viral load—and what it means for your health and your sex life. Read More

Biktarvy, a new HIV combo pill recently approved by the FDA

Biktarvy, a new HIV combo pill recently approved by the FDA

, by Jennifer Cocohoba, PharmD, AAHIVE

This week, the FDA granted approval of Gilead Science’s single-table combo pill of bictegravir, emtricitabine, and tenofovir alafenamide named Biktarvy. Read More